|Bid||69.64 x 900|
|Ask||69.72 x 900|
|Day's Range||69.21 - 71.26|
|52 Week Range||61.28 - 101.24|
|Beta (5Y Monthly)||1.29|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 02, 2022 - Aug 08, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||118.33|
Subscribe to Yahoo Finance Plus to view Fair Value for SRPT
Cell and gene therapy researchers and companies in Ohio attract buzz, but a panel of experts said the industry needs to do better at promoting a statewide brand to attract talent.
Bayer (BAYRY) beats estimates for both earnings and revenues in the first quarter of 2022.
Quite a few insiders have dramatically grown their holdings in Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) over the past...